Total raised in public, private and other financings of biopharma companies, comparing 2023 vs. 2022 vs. 2021 vs. 2020 vs. 2019.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Foundation Medicine, Inspire Medical Systems.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Dxvx, Edgecap, Eitan Medical, LTS, Soteria, T2 Biosystems.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edwards Lifesciences.

New hires and promotions in the med-tech industry, including: Bayer, Sword Health.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biogen, Eisai, Innate, Merck & Co., Novaliq, Pipeline, Rocket.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Emris, Hyloris, Lantern.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annovis, Arvinas, Azafaros, Cingulate, Lianbio, Repare, Ultimovacs.

Biopharmas raising money in public or private financings, including: Aytu, Effector, Elevation Oncology, Nrx.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avita Medical, Corneat Vision, Femasys, FX Solutions.